Magnesium and Arthritis Pathogenesis
镁与关节炎发病机制
基本信息
- 批准号:10322996
- 负责人:
- 金额:$ 36.92万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2019
- 资助国家:美国
- 起止时间:2019-01-15 至 2023-12-31
- 项目状态:已结题
- 来源:
- 关键词:AffectAgonistAntibioticsApplications GrantsArthritisArthritogenicAutomobile DrivingBacteriaBacteroides fragilisCXCL10 geneCell Differentiation processCell physiologyCellsChemotactic FactorsChronicClinicalCollagen ArthritisComplementCytokine SignalingDataDeformityDevelopmentDietDiseaseDisease remissionEventFOXP3 geneFibroblastsFlow CytometryGene ExpressionGrantHistologicHumanIL17 geneIn VitroInflammation MediatorsInflammatoryInterleukin-1 betaInterleukin-10Interleukin-17Interleukin-6JointsLife ExpectancyMagnesiumMediatingMediator of activation proteinModelingMusOnset of illnessPathogenesisPathogenicityPredispositionProductionRattusRegulationRegulatory T-LymphocyteReproducibilityRheumatoid ArthritisRibosomesRoleSerumSeveritiesSeverity of illnessSignal TransductionSmall Interfering RNASystemT cell differentiationT-LymphocyteT-Lymphocyte SubsetsTestingTissuesantagonistautoimmune arthritisbasecell motilitychronic autoimmune diseasedisability riskdisorder controlexperimental studygut microbiomeimprovedin vivoinhibitorinnovationjoint destructionjoint injuryknock-downnovelnovel therapeuticspristane induced arthritisprotective effecttranscriptome sequencing
项目摘要
ABSTRACT
Rheumatoid arthritis (RA) is a common and chronic autoimmune arthritis that causes erosive joint damage
and deformities, with increased risk for disability and reduced life expectancy. Recent new therapies have
significantly improved disease control but remission remains uncommon and new and better treatments are
needed. We have recently discovered a previously unrecognized role for magnesium in the regulation of
arthritis. Specifically, a short-term experimental low magnesium diet was highly protective reducing arthritis
severity and histologic joint damage in pristane-induced arthritis (PIA) in rats and collagen-induced arthritis
(CIA) in mice, two well-established models or RA. Our observations suggest that the arthritis-protective
effect involves a magnesium-dependent interference with Treg, Tr1 or Th17 cell development and/or
localization to the joint. The specific aims are: AIM 1. To determine the role of magnesium on Treg, Tr1
and Th17 T cell differentiation and in fibroblast-like synoviocytes (FLS). Subaim 1. To characterize the
effect of reduced magnesium conditions on in vitro Treg, Tr1 and Th17 T cell differentiation and function.
Subaim 2. To determine the role of specific magnesium channels in Treg, Tr1 and Th17 differentiation. The
role of specific magnesium channels on in vitro Treg, Tr1 and Th17 differentiation will be examined in
experiments with siRNA knock-down, and with antagonists and agonists. Subaim 3. The role of magnesium
in fibroblast-like synoviocyte (FLS) production of of pro-inflammatory mediators. We will examine whether
low concentrations of magnesium reduce the RA FLS production of inflammatory factors including those
required for the influx of Th17 and other cells into the synovial tissues, and whether a specific magnesium
channel accounts for that. AIM 2. In vivo effect of a short-term experimental low magnesium diet on
established arthritis, on the development of protective and pathogenic T cell subsets, and on the
intestinal microbiome. Subaim 1. To determine the effect of a short-term low magnesium diet initiated
after the onset of disease on arthritis severity and joint damage. It is hypothesized that a low-magnesium
diet initiated after the onset of arthritis (CIA) will significantly reduce disease severity and histologic joint
damage. The role of specific magnesium channels will be examined with inhibitors. Subaim 2. To determine
the role of reduced magnesium conditions on Treg, Tr1 and Th17 cell differentiation in vivo. Will examine
the effect of low and high magnesium diets on the numbers of Treg, Tr1 and Th17 cells in arthritis induced
in mice with inducible IL17-eGFP/Foxp3-mRFP. Submaim 3. Effect of reduced magnesium conditions on
the gut microbiome. We have hypothesized that the low magnesium diet protective effect could be related to
changes induced by the diet in the gut microbiome and will comprehensively examine that.
摘要
类风湿性关节炎(RA)是一种常见的慢性自身免疫性关节炎,可引起关节糜烂性损伤
和畸形,增加了残疾的风险,缩短了预期寿命。最近的新疗法
显著改善疾病控制,但缓解仍然罕见,新的更好的治疗方法,
needed.我们最近发现了一个以前未被认识的作用,镁在调节
关节炎具体来说,短期实验性低镁饮食对减少关节炎具有高度保护作用
降植烷诱导的大鼠关节炎(PIA)和胶原诱导的关节炎的严重程度和组织学关节损伤
(CIA)在小鼠中,两个良好建立的模型或RA。我们的观察表明,关节炎保护
效应涉及对Treg、Tr 1或Th 17细胞发育的镁依赖性干扰,和/或
定位到关节。具体目标是:目标1。为了确定镁对Treg、Tr 1
和Th 17 T细胞分化以及成纤维细胞样滑膜细胞(FLS)中。Subaim 1.表征
镁减少条件对体外Treg、Tr 1和Th 17 T细胞分化和功能的影响。
Subaim 2.确定特异性镁通道在Treg、Tr 1和Th 17分化中的作用。的
特异性镁通道对体外Treg、Tr 1和Th 17分化的作用将在
用siRNA敲低以及用拮抗剂和激动剂的实验。Subaim 3.镁的作用
在成纤维细胞样滑膜细胞(FLS)中产生促炎介质。我们将研究是否
低浓度的镁可减少RA FLS产生炎症因子,
Th 17和其他细胞流入滑膜组织所需的,以及是否有特定的镁
频道对此表示。AIM 2.短期实验性低镁饮食对大鼠骨骼肌的影响
建立关节炎,对保护性和致病性T细胞亚群的发展,以及对
肠道微生物组Subaim 1.为了确定短期低镁饮食的影响,
发病后对关节炎病情的严重程度和关节的损害。据推测,低镁
在关节炎(CIA)发作后开始的饮食将显著降低疾病的严重程度和关节的组织学改变。
损害将用抑制剂检查特定镁通道的作用。Subaim 2.以确定
体内镁减少条件对Treg、Tr 1和Th 17细胞分化的作用。将审查
低镁和高镁饮食对关节炎大鼠Treg、Tr 1和Th 17细胞数量的影响
在具有诱导型IL 17-eGFP/Foxp 3-mRFP的小鼠中。3.还原镁条件对
肠道微生物组我们假设低镁饮食的保护作用可能与
饮食引起的肠道微生物组的变化,并将全面检查。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Percio S Gulko其他文献
Percio S Gulko的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Percio S Gulko', 18)}}的其他基金
Identification of arthritis genes in DAxF344 congenic rats
DAxF344同系大鼠关节炎基因的鉴定
- 批准号:
7664476 - 财政年份:2005
- 资助金额:
$ 36.92万 - 项目类别:
Identification of arthritis genes in DAxF344 congenic rats.
DAxF344 同类大鼠关节炎基因的鉴定。
- 批准号:
7126533 - 财政年份:2005
- 资助金额:
$ 36.92万 - 项目类别:
相似国自然基金
Agonist-GPR119-Gs复合物的结构生物学研究
- 批准号:32000851
- 批准年份:2020
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
相似海外基金
S1PR1 agonistによる脳血液関門制御を介した脳梗塞の新規治療法開発
S1PR1激动剂调节血脑屏障治疗脑梗塞新方法的开发
- 批准号:
24K12256 - 财政年份:2024
- 资助金额:
$ 36.92万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
AHR agonistによるSLE皮疹の新たな治療薬の開発
使用 AHR 激动剂开发治疗 SLE 皮疹的新疗法
- 批准号:
24K19176 - 财政年份:2024
- 资助金额:
$ 36.92万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Evaluation of a specific LXR/PPAR agonist for treatment of Alzheimer's disease
特定 LXR/PPAR 激动剂治疗阿尔茨海默病的评估
- 批准号:
10578068 - 财政年份:2023
- 资助金额:
$ 36.92万 - 项目类别:
AUGMENTING THE QUALITY AND DURATION OF THE IMMUNE RESPONSE WITH A NOVEL TLR2 AGONIST-ALUMINUM COMBINATION ADJUVANT
使用新型 TLR2 激动剂-铝组合佐剂增强免疫反应的质量和持续时间
- 批准号:
10933287 - 财政年份:2023
- 资助金额:
$ 36.92万 - 项目类别:
Targeting breast cancer microenvironment with small molecule agonist of relaxin receptor
用松弛素受体小分子激动剂靶向乳腺癌微环境
- 批准号:
10650593 - 财政年份:2023
- 资助金额:
$ 36.92万 - 项目类别:
AMPKa agonist in attenuating CPT1A inhibition and alcoholic chronic pancreatitis
AMPKa 激动剂减轻 CPT1A 抑制和酒精性慢性胰腺炎
- 批准号:
10649275 - 财政年份:2023
- 资助金额:
$ 36.92万 - 项目类别:
Investigating mechanisms underpinning outcomes in people on opioid agonist treatment for OUD: Disentangling sleep and circadian rhythm influences on craving and emotion regulation
研究阿片类激动剂治疗 OUD 患者结果的机制:解开睡眠和昼夜节律对渴望和情绪调节的影响
- 批准号:
10784209 - 财政年份:2023
- 资助金额:
$ 36.92万 - 项目类别:
A randomized double-blind placebo controlled Phase 1 SAD study in male and female healthy volunteers to assess safety, pharmacokinetics, and transient biomarker changes by the ABCA1 agonist CS6253
在男性和女性健康志愿者中进行的一项随机双盲安慰剂对照 1 期 SAD 研究,旨在评估 ABCA1 激动剂 CS6253 的安全性、药代动力学和短暂生物标志物变化
- 批准号:
10734158 - 财政年份:2023
- 资助金额:
$ 36.92万 - 项目类别:
A novel nanobody-based agonist-redirected checkpoint (ARC) molecule, aPD1-Fc-OX40L, for cancer immunotherapy
一种基于纳米抗体的新型激动剂重定向检查点 (ARC) 分子 aPD1-Fc-OX40L,用于癌症免疫治疗
- 批准号:
10580259 - 财政年份:2023
- 资助金额:
$ 36.92万 - 项目类别:
Identification and characterization of a plant growth promoter from wild plants: is this a novel plant hormone agonist?
野生植物中植物生长促进剂的鉴定和表征:这是一种新型植物激素激动剂吗?
- 批准号:
23K05057 - 财政年份:2023
- 资助金额:
$ 36.92万 - 项目类别:
Grant-in-Aid for Scientific Research (C)














{{item.name}}会员




